Net Asset Value(s)

The table reports Palmer Square EUR CLO Senior Debt Index UCITS ETF data dated 12/10/2026. Both listed share classes show 1,025,000 units outstanding and shareholder equity of 53,245,703.65; NAV per share is 43.9052 GBP for ticker PCLS and 51.947 EUR for ticker PCL0.

Analysis

This is a low-information NAV snapshot, not a catalyst. The GBP and EUR NAVs appear consistent with currency translation, but the table alone does not establish whether the two lines are separate trading lines, how FX was applied, or whether either NAV is executable. Do not interpret the difference as an arbitrage without confirming the share-class terms, contemporaneous FX rate, and market prices.

For PCLS/PCL0, the relevant risk is the gap between reported NAV and realizable value in stressed CLO markets: underlying loan liquidity can deteriorate faster than periodic marks adjust, while ETF spreads may widen. That is a structural liquidity and credit-spread exposure, not evidence of a current impairment from this data. Near term, verify the valuation date convention and bid/ask premiums; over 1–3 months, monitor CLO spreads, loan prices, and fund flows. A persistent premium/discount or widening spreads would matter more than this isolated NAV report. No directional trade is supported.

Key Decisions for Investors

• No trade on this release alone; it provides no demonstrated change in credit quality, portfolio composition, or executable pricing.
• Verify whether PCLS and PCL0 are distinct trading lines or currency presentations, and reconcile the NAVs using the applicable FX fixing and valuation timestamp before considering any relative-value position.
• Alert on a sustained ETF discount to NAV, materially wider bid-ask spreads, or deterioration in underlying CLO/loan liquidity; these would indicate a potentially actionable liquidity mismatch.
• For existing exposure, track CLO spread moves, loan-price weakness, defaults, and fund flows over the next 1–3 months; a sharp spread widening or persistent NAV discount would falsify the benign interpretation.